Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection
β Scribed by M. C. Nahata; M. T. Brady
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 264 KB
- Volume
- 48-48
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
β¦ Synopsis
The objective of this study was to determine the pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus (HIV) infection. After an overnight fast, a single dose of either 2 rag" kg-1 or 8 mg kg-1 was administered in a suspension; five children received 2 mg'kg 1 and four 8 mg'kg -1 (ages 5-13 years). Blood samples were collected at various times on day 1, and once daily on days 2-7 after the dose. Fluconazole serum concentrations were measured by gas chromatography. At the dose of 2 mg'kg -1, the Cmax, AUC (0-oo), and tl/2 ranged from 2.3-4.4 btg'm1-1, 84.9-136 gg.h'm1-1, and 19.8 34.8 h, respectively. At the dose of 8 mg'kg 1 the Cmax, AUC (0-~), and tl/2 ranged from 5.4-12.1 btg ml-1,330-684 gg h' ml -1, and 25.6-42.3 h, respectively. When compared with published data in healthy adults, fluconazole achieved similar serum concentrations in the present group of children, indicating a nearly complete degree of absorption.
π SIMILAR VOLUMES
Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome/Spanish Group for the Study of Acquired Immunodeficiency Syndrome Prospective Cohort Study.'' 1 Surprisingly, in a cohort of 84 consecutive patients coinfected with human immunodeficiency virus (HIV) and he